Third-party tested · 1–3 day shippingShop the catalog
Back to catalog
NAD+ - Emetrix Research Labs branded vial

Metabolic Studies

NAD+

Nicotinamide adenine dinucleotide — cellular metabolism research.

In Stock
Lyophilized powder
$79.00$58.0027% OFF
Research-use disclaimer: For research use only. Not for human or veterinary use.

Specifications

Formula
C21H27N7O14P2
Molecular Weight
663.43 g/mol
Storage
Store lyophilized at -20°C
Form
Lyophilized powder

Description

ERM-828 is a research-grade NAD+ compound studied in mitochondrial function, sirtuin activity, and cellular energy pathways.

Compound Guide

What is NAD+?

Cellular Energy & Longevity Signaling

LongevityMitochondrialCognitive

Nicotinamide adenine dinucleotide is a coenzyme present in every living cell, central to mitochondrial electron transport and to sirtuin and PARP enzyme activity. Tissue NAD+ concentration declines measurably with age, making direct repletion one of the most studied approaches in longevity research.

Areas of Research Interest

Summarized from published research findings. Not medical guidance or prescribing information.

Mitochondrial Output

Direct substrate for the electron transport chain and cellular ATP production.

Sirtuin Activation

NAD+ is the required cofactor for SIRT1–SIRT7, the enzymes central to longevity research.

Cognitive Endpoints

Neuronal energy availability and clarity measures appear across NAD+ literature.

DNA Repair

PARP enzymes consume NAD+ during DNA-damage response; repletion supports that capacity.

Metabolic Rate

Studied for substrate-utilization efficiency at the cellular level.

Circadian Signaling

NAD+ oscillates on a daily rhythm and interacts with clock-gene expression.

Reconstitution

  • 100 mg vial + 2 mL bacteriostatic water = 50 mg/mL
  • 500 mg vial + 5 mL bacteriostatic water = 100 mg/mL
  • At 50 mg/mL, 10 units on a U-100 syringe = 5 mg
Open the peptide calculator

Suggested research protocol

  • Route studied: subcutaneous; slow administration is standard.
  • Timing: morning, as evening administration is associated with alertness in logs.
  • Cycle: 2–4 week blocks with escalating amounts, followed by a maintenance interval.
  • Refrigerate and protect from light.

Dosing Reference

PhaseAmountFrequency
Introductory10–25 mgDaily
Standard50 mgDaily
Maintenance50–100 mg2–3× weekly

Handling & Notes

  • Rapid administration is consistently associated with transient flushing — slow delivery is the standard control.
  • Begin at the low end of the range; NAD+ tolerance is highly individual in the literature.
  • Solution may develop color with light exposure; store in the dark.

This guide is provided for informational and research reference only. NAD+ is intended for laboratory research use exclusively and is not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary consumption.